JP2008524142A5 - - Google Patents

Download PDF

Info

Publication number
JP2008524142A5
JP2008524142A5 JP2007545942A JP2007545942A JP2008524142A5 JP 2008524142 A5 JP2008524142 A5 JP 2008524142A5 JP 2007545942 A JP2007545942 A JP 2007545942A JP 2007545942 A JP2007545942 A JP 2007545942A JP 2008524142 A5 JP2008524142 A5 JP 2008524142A5
Authority
JP
Japan
Prior art keywords
compound
formula
alkenyl
alkoxy
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007545942A
Other languages
English (en)
Japanese (ja)
Other versions
JP5224816B2 (ja
JP2008524142A (ja
Filing date
Publication date
Priority claimed from GBGB0427603.6A external-priority patent/GB0427603D0/en
Application filed filed Critical
Publication of JP2008524142A publication Critical patent/JP2008524142A/ja
Publication of JP2008524142A5 publication Critical patent/JP2008524142A5/ja
Application granted granted Critical
Publication of JP5224816B2 publication Critical patent/JP5224816B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007545942A 2004-12-16 2005-12-14 N−置換サリチルアミドの製造法 Expired - Fee Related JP5224816B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0427603.6 2004-12-16
GBGB0427603.6A GB0427603D0 (en) 2004-12-16 2004-12-16 Organic compounds
PCT/EP2005/013454 WO2006063821A1 (en) 2004-12-16 2005-12-14 Manufacture process of n-substituted salicylamides

Publications (3)

Publication Number Publication Date
JP2008524142A JP2008524142A (ja) 2008-07-10
JP2008524142A5 true JP2008524142A5 (enExample) 2009-02-05
JP5224816B2 JP5224816B2 (ja) 2013-07-03

Family

ID=34090175

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007545942A Expired - Fee Related JP5224816B2 (ja) 2004-12-16 2005-12-14 N−置換サリチルアミドの製造法

Country Status (24)

Country Link
US (1) US8461385B2 (enExample)
EP (2) EP1838664B1 (enExample)
JP (1) JP5224816B2 (enExample)
KR (1) KR101287233B1 (enExample)
CN (1) CN101080384B (enExample)
AR (1) AR055007A1 (enExample)
AU (1) AU2005315850B2 (enExample)
BR (1) BRPI0519327A2 (enExample)
CA (1) CA2587213C (enExample)
ES (1) ES2547349T3 (enExample)
GB (1) GB0427603D0 (enExample)
GT (1) GT200500353A (enExample)
IL (1) IL183366A0 (enExample)
MA (1) MA29092B1 (enExample)
MX (1) MX2007007211A (enExample)
NO (1) NO338969B1 (enExample)
PE (1) PE20060740A1 (enExample)
PL (1) PL1838664T3 (enExample)
PT (1) PT1838664E (enExample)
RU (1) RU2404158C2 (enExample)
TN (1) TNSN07229A1 (enExample)
TW (1) TW200635880A (enExample)
WO (1) WO2006063821A1 (enExample)
ZA (1) ZA200703826B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006292337B8 (en) 2005-09-19 2013-02-07 Emisphere Technologies, Inc. Crystalline forms of the di-sodium salt of N-(5-chlorosalicyloyl)-8-aminocaprylic acid
WO2009059188A1 (en) 2007-11-02 2009-05-07 Emisphere Technologies, Inc. Method of treating vitamin b12 deficiency
CN109473182B (zh) * 2018-11-12 2021-10-19 北京北排科技有限公司 一种基于深度信念网络的mbr膜透水率智能检测方法
AU2020277650B2 (en) * 2019-05-20 2025-03-13 Lonza Guangzhou Pharmaceutical Ltd. Method for preparation of carsalam
CN115260116B (zh) * 2022-08-19 2024-04-12 株洲壹诺生物技术有限公司 8-(2-羟基苯甲酰胺基)辛酸钠及苯并噁嗪-2,4-二酮和8-溴辛酸乙酯的制法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU382610A1 (ru) * 1968-07-08 1973-05-25 Способ получения амидов карбоновых кислот
NZ534409A (en) 1999-04-05 2006-03-31 Emisphere Tech Inc Disodium salts, monohydrates, and ethanol solvates for delivering active agents
AP2001002377A0 (en) * 1999-06-25 2001-12-31 Inst For Pharm Discovery Inc Substituted phenoxyacetic acids.
CA2402719C (en) * 2000-03-21 2012-03-20 Emisphere Technologies, Inc. Method of preparing alkylated salicylamides via a dicarboxylate intermediate
AU2001275231A1 (en) 2000-06-02 2001-12-11 Emisphere Technologies, Inc. Method of preparing salicylamides
US7351741B2 (en) * 2000-06-29 2008-04-01 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
ATE396967T1 (de) * 2000-09-06 2008-06-15 Emisphere Tech Inc (5-(2-hydroxy-4-chlorbenzoyl)valeriansäure und deren salze, und zusammensetzungen zur zuführung von wirkstoffen, die diese verbindungen enthalten
US7049283B2 (en) 2000-12-06 2006-05-23 Novartis Ag Pharmaceutical compositions for the oral delivery of pharmacologically active agents
EP1469827B1 (en) * 2002-01-09 2017-12-27 Emisphere Technologies, Inc. Polymorphs of sodium 4- (4-chloro-2-hydroxybenzoyl)amino butanoate
CN1332711C (zh) 2002-02-20 2007-08-22 埃米球科技有限公司 施用glp-1分子的方法
US20050054557A1 (en) * 2002-05-09 2005-03-10 Goldberg Michael M. Compositions for delivering parathyroid hormone and calcitonin

Similar Documents

Publication Publication Date Title
TWI343786B (en) Diamine derivative, method for manufacturing the same and plant disease control agent containing the sane as active compound
JP2005500988A5 (enExample)
CA2632626C (en) Ester prodrugs of 2'-fluoro-2'-alkyl-2'-deoxycytidines and their use in the treatment of hcv infection
PE20081164A1 (es) Nuevos compuestos 521
JP2004529125A5 (enExample)
JP2012507568A5 (enExample)
JP2005526011A5 (enExample)
JP2008509166A5 (enExample)
JP2006526031A5 (enExample)
CA2565660A1 (en) Ortho substituted aryl or heteroaryl amide compounds
CA2504730A1 (en) Cephem compounds
ES2633838T3 (es) Método para preparar derivados tricíclicos
CY1113873T1 (el) Παραγωγα hydroxybenzamide σαν παραγοντες καταστολης της hsp90
JP2019516713A5 (enExample)
RU2010147832A (ru) Диэфирные пролекарства налмефена
JP2008540414A5 (enExample)
ATE507212T1 (de) Morpholine als 5ht2c-agonisten
BRPI0409471A (pt) processo para a preparação de 2-cianopirrolidinas n-substituìdas
JP2008524142A5 (enExample)
RU2003134629A (ru) Соединения цефема
JP2005516898A5 (enExample)
JP2006514956A5 (enExample)
DE602006008962D1 (de) Verfahren zur herstellung von valsartan
RU2009103818A (ru) Водная лекарственная композиция 4-[(4-карбоксибутил)-{2-[(4-фенетилбензил)окси)-фенетил}амино)метил)-бензойной кислоты
JP2004523567A5 (enExample)